Healthcare -
Biotechnology - NASDAQ - US
$ 3.69
2.5 %
$ 39.8 M
Market Cap
-2.07
P/E
LTRN - STOCK-BASED COMPENSATION
Stock-based Compensation LTRN - Lantern Pharma Inc.
1.07 M
LAST VALUE
5.37%
2 YEAR CAGR
41.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR